Aurobindo Pharma’s unit -- Aurobindo Pharma USA Inc is recalling 2,820 bottles of Metoprolol tartrate tablets in the US market due to presence of foreign substance: product complaints received for the presence of metal wire in one tablet. Metoprolol tartrate tablets are used to treat high blood pressure. The company initiated Class II recall on September 9 this year.
As per USFDA, a Class-II recall is initiated in a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
